Shareholders Approve Drastic Capital Reduction and Reorganization, Enabling Balance Sheet Cleanup

summarizeSummary

Haoxi Health shareholders approved a major capital reduction and reorganization, drastically lowering the par value of shares to enable the company to offset accumulated losses and gain financial flexibility, though it also facilitates potential future dilution.

check_boxKey Events · Corporate Governance and Compliance · HAO

• Share Capital Reduction Approved

  Shareholders voted to reduce and reorganize the authorized share capital from US$35.2 trillion to US$11 million, a significant structural change.

• Par Value Drastically Lowered

  The par value of Class A and Class B Ordinary Shares was reduced from US$0.32 to US$0.0000001, enabling greater flexibility for future share issuances.

• Accumulated Losses Offset

  The credit generated from the capital reduction will be transferred to a distributable reserve account to eliminate or set off accumulated losses, cleaning up the company's balance sheet.

• New Articles of Association Adopted

  The Ninth Amended and Restated Memorandum and Articles of Association were approved to reflect these fundamental capital changes.

auto_awesomeAnalysis · HAO · Trade & Services

Haoxi Health shareholders have approved a significant reorganization of the company's share capital, drastically reducing the par value of its Class A and Class B Ordinary Shares from $0.32 to $0.0000001. This critical move allows the company to transfer the resulting credit to a distributable reserve account, which can be used to eliminate accumulated losses. While this cleans up the balance sheet, the need for such extreme measures highlights severe past financial distress and sets the stage for potentially massive future dilution due to the astronomical number of authorized shares at a near-zero par value.